Cutera (CUTR) Scheduled to Post Earnings on Monday

Cutera (NASDAQ:CUTR) is scheduled to be posting its quarterly earnings results after the market closes on Monday, February 12th. Analysts expect Cutera to post earnings of $0.35 per share for the quarter.

Cutera (NASDAQ:CUTR) last released its earnings results on Tuesday, November 7th. The medical device company reported $0.42 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.08 by $0.34. The firm had revenue of $38.17 million for the quarter, compared to analysts’ expectations of $34.82 million. Cutera had a net margin of 7.99% and a return on equity of 18.73%. The company’s quarterly revenue was up 26.1% on a year-over-year basis. During the same period in the previous year, the company earned $0.12 earnings per share. On average, analysts expect Cutera to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Cutera (NASDAQ CUTR) opened at $49.90 on Monday. The firm has a market cap of $698.85, a PE ratio of 66.53, a price-to-earnings-growth ratio of 1.49 and a beta of 0.41. Cutera has a 52 week low of $18.50 and a 52 week high of $52.90.

In other news, EVP Miguel Pardos sold 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, December 12th. The shares were sold at an average price of $46.70, for a total value of $467,000.00. Following the sale, the executive vice president now owns 39,698 shares of the company’s stock, valued at $1,853,896.60. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director David B. Apfelberg sold 1,000 shares of the business’s stock in a transaction that occurred on Friday, November 17th. The shares were sold at an average price of $42.55, for a total transaction of $42,550.00. Following the completion of the sale, the director now directly owns 8,055 shares in the company, valued at approximately $342,740.25. The disclosure for this sale can be found here. In the last three months, insiders sold 27,968 shares of company stock worth $1,274,346. Insiders own 11.60% of the company’s stock.

A number of research analysts have weighed in on the stock. Zacks Investment Research upgraded shares of Cutera from a “sell” rating to a “hold” rating in a research note on Tuesday, January 9th. BidaskClub upgraded shares of Cutera from a “hold” rating to a “buy” rating in a research note on Tuesday, December 12th. Finally, Maxim Group reiterated a “hold” rating on shares of Cutera in a research note on Wednesday, November 8th. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $37.33.

ILLEGAL ACTIVITY WARNING: This article was originally reported by American Banking News and is the sole property of of American Banking News. If you are reading this article on another publication, it was illegally stolen and republished in violation of US & international copyright & trademark legislation. The original version of this article can be viewed at https://www.americanbankingnews.com/2018/02/05/cutera-cutr-scheduled-to-post-earnings-on-monday.html.

About Cutera

Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.

Earnings History for Cutera (NASDAQ:CUTR)

Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply